Advances in nucleic acid-targeted therapies for cardiovascular disease prevention

医学 核酸 疾病 重症监护医学 生物信息学 计算生物学 内科学 生物 遗传学
作者
Umidakhon Makhmudova,Elisabeth Steinhagen‐Thiessen,Massimo Volpe,Ulf Landmesser
出处
期刊:Cardiovascular Research [Oxford University Press]
卷期号:120 (10): 1107-1125 被引量:7
标识
DOI:10.1093/cvr/cvae136
摘要

Abstract Nucleic acid-based therapies are being rapidly developed for prevention and management of cardiovascular diseases (CVD). Remarkable advancements have been achieved in the delivery, safety, and effectiveness of these therapeutics in the past decade. These therapies can also modulate therapeutic targets that cannot be sufficiently addressed using traditional drugs or antibodies. Among the nucleic acid-targeted therapeutics under development for CVD prevention are RNA-targeted approaches, including antisense oligonucleotides (ASO), small interfering RNAs (siRNA), and novel genome editing techniques. Genetic studies have identified potential therapeutic targets that are suggested to play a causative role in development and progression of CVD. RNA- and DNA-targeted therapeutics can be particularly well delivered to the liver, where atherogenic lipoproteins and angiotensinogen (AGT) are produced. Current targets in lipid metabolism include proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein A (ApoA), apolipoprotein C3 (ApoC3), angiopoietin-like 3 (ANGPTL3). Several large-scale clinical development programs for nucleic acid-targeted therapies in cardiovascular prevention are under way, which may also be attractive from a therapy adherence point of view, given the long action of these therapeutics. In addition to genome editing, the concept of gene transfer is presently under assessment in preclinical and clinical investigations as a potential approach for addressing low-density lipoprotein receptor deficiency. Furthermore, ongoing research is exploring the use of RNA-targeted therapies to treat arterial hypertension by reducing hepatic angiotensinogen (AGT) production. This review summarizes the rapid translation of siRNA and ASO therapeutics as well as gene editing into clinical studies to treat dyslipidemia and arterial hypertension for CVD prevention. It also outlines potential innovative therapeutic options that are likely relevant to the future of cardiovascular medicine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
11完成签到,获得积分10
1秒前
1秒前
偏爱走夜路完成签到,获得积分20
1秒前
李爱国应助2021采纳,获得10
3秒前
靓丽的安筠完成签到,获得积分20
4秒前
4秒前
丰荣完成签到,获得积分10
5秒前
嗯哼发布了新的文献求助10
5秒前
Ava应助科研通管家采纳,获得10
8秒前
8秒前
乐乐应助科研通管家采纳,获得10
8秒前
慕青应助科研通管家采纳,获得10
8秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
LaTeXer应助科研通管家采纳,获得200
8秒前
Singularity应助科研通管家采纳,获得10
8秒前
SYLH应助科研通管家采纳,获得10
8秒前
SYLH应助科研通管家采纳,获得10
8秒前
8秒前
SYLH应助科研通管家采纳,获得10
8秒前
今后应助科研通管家采纳,获得10
9秒前
科研通AI5应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
化学天空完成签到,获得积分10
9秒前
卡机了完成签到,获得积分10
9秒前
wwl关闭了wwl文献求助
9秒前
10秒前
科研小白完成签到,获得积分10
11秒前
12秒前
嗯哼完成签到,获得积分10
14秒前
ly发布了新的文献求助10
14秒前
14秒前
温柔的惜儿应助刘隅采纳,获得20
14秒前
我是老大应助迅速哈密瓜采纳,获得10
14秒前
15秒前
Guan发布了新的文献求助10
15秒前
bc给迟青的求助进行了留言
16秒前
科研小白发布了新的文献求助10
17秒前
充电宝应助wyb采纳,获得10
17秒前
17秒前
高分求助中
Thinking Small and Large 500
Algorithmic Mathematics in Machine Learning 500
Mapping the Stars: Celebrity, Metonymy, and the Networked Politics of Identity 400
Getting Published in SSCI Journals: 200+ Questions and Answers for Absolute Beginners 300
The direct observation of dislocations 200
Reference Guide for Dynamic Models of HVAC Equipment 200
A Treatise on Hydrostatics and Hydrodynamics 200
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3836508
求助须知:如何正确求助?哪些是违规求助? 3378791
关于积分的说明 10506129
捐赠科研通 3098486
什么是DOI,文献DOI怎么找? 1706518
邀请新用户注册赠送积分活动 821062
科研通“疑难数据库(出版商)”最低求助积分说明 772431